14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $5.34 $19.02 Monday, 6th May 2024 OTLK stock ended at $8.50. This is 1.16% less than the trading day before Friday, 3rd May 2024. During the day the stock fluctuated 5.44% from a day low at $8.45 to a day high of $8.91.
90 days $17.30 $19.02
52 weeks $16.32 $20.85

Historical Outlook Therapeutics Inc. prices

Date Open High Low Close Volume
Jun 13, 2023 $1.70 $1.71 $1.60 $1.64 1 805 829
Jun 12, 2023 $1.73 $1.75 $1.59 $1.65 2 034 538
Jun 09, 2023 $1.78 $1.78 $1.68 $1.73 934 779
Jun 08, 2023 $1.95 $1.95 $1.68 $1.74 2 373 298
Jun 07, 2023 $1.85 $1.99 $1.83 $1.89 2 528 207
Jun 06, 2023 $1.80 $2.03 $1.76 $1.79 2 834 202
Jun 05, 2023 $1.62 $1.90 $1.57 $1.75 2 731 612
Jun 02, 2023 $1.65 $1.65 $1.51 $1.61 1 295 728
Jun 01, 2023 $1.51 $1.66 $1.49 $1.63 1 222 727
May 31, 2023 $1.52 $1.58 $1.39 $1.50 1 153 380
May 30, 2023 $1.45 $1.52 $1.39 $1.50 891 803
May 26, 2023 $1.47 $1.49 $1.35 $1.48 561 126
May 25, 2023 $1.53 $1.53 $1.33 $1.35 1 177 311
May 24, 2023 $1.52 $1.58 $1.45 $1.49 1 008 677
May 23, 2023 $1.67 $1.67 $1.47 $1.52 1 912 253
May 22, 2023 $1.40 $1.65 $1.39 $1.63 3 019 741
May 19, 2023 $1.24 $1.37 $1.21 $1.34 1 957 992
May 18, 2023 $1.23 $1.23 $1.18 $1.22 471 544
May 17, 2023 $1.20 $1.22 $1.18 $1.20 552 421
May 16, 2023 $1.19 $1.24 $1.18 $1.19 789 004
May 15, 2023 $1.15 $1.21 $1.14 $1.20 562 071
May 12, 2023 $1.14 $1.17 $1.13 $1.15 354 405
May 11, 2023 $1.20 $1.20 $1.13 $1.13 689 530
May 10, 2023 $1.17 $1.20 $1.16 $1.18 738 718
May 09, 2023 $1.14 $1.22 $1.12 $1.17 498 510
Click to get the best stock tips daily for free!

About Outlook Therapeutics Inc.

Outlook Therapeutics. Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration and lice... OTLK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT